幹細胞治療市場は、2020年から2027年のレビュー期間中に10.74%という著しいCAGRを達成すると予想されています。幹細胞療法は、あらゆる病気の治療に利用されます。世界市場の成長の背景には、慢性疾患の増加、医療産業の拡大、医学研究への支出増などがあります。さらに、幹細胞治療に関する臨床研究の増加が、レビュー期間中の世界市場の成長を促進しています。
幹細胞治療の世界市場は、2020年には57億3,512万ドルとなり、予測期間中に健全な市場拡大を記録すると予想されています。さらに、幹細胞治療の臨床研究件数が増加していることも、市場発展の原動力となっています。いずれにせよ、幹細胞治療の初期段階における精神的な不安や、関連する多額の費用が、将来的に幹細胞治療市場の発展を妨げる可能性があります。
保護され成功した幹細胞治療アイテムを提供するための拡大された官民の資金調達、および現地の中央メンバーの存在は、アメリカの幹細胞治療市場を推進する主な考慮事項です。
アジア太平洋地域は、幹細胞治療において最も急速に発展している地域であり、急速に成長し、多数のプレーヤーが台頭しています。また、疾病の蔓延が進んでいることや、幹細胞治療薬の普及が進んでいることも、市場の発展を後押ししていると思われます。
中東およびアフリカの幹細胞治療市場は、国民の意識が欠如しており、国民の合理性が制限されているため、限られた開発を観察することに依存しています。 とはいえ、再生医療への応用が進んでいます。
本レポートは、COVID-19の大流行があらゆる領域の様々な産業や業種に与える影響を継続的に追跡しています。当社の調査レポートには、COVID-19が各産業に与える影響による低下と上昇を理解するのに役立つ情報が記載されています。また、関心のある市場の需要と供給のギャップを特定するのに役立ちます。さらに、このレポートは、分析、政府規制の修正、およびその他の多くの有用な洞察に役立ちます。
目次
TABLE OF CONTENT
Chapter 1. REPORT PROLOGUE
Chapter 2. MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.2.1 RESEARCH OBJECTIVE
2.2.2 ASSUMPTIONS
2.2.3 LIMITATIONS
Chapter 3. RESEARCH METHODOLOGY
3.1 INTRODUCTION
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
Chapter 4. MARKET DYNAMICS
4.1 DRIVERS
4.2 RESTRAINTS
4.3 OPPORTUNITIES
4.4 CHALLENGES
4.5 MACROECONOMIC INDICATORS
4.6 TECHNOLOGY TRENDS & ASSESSMENT
Chapter 5. MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF RIVALRY
5.2 VALUE CHAIN ANALYSIS
5.3 INVESTMENT FEASIBILITY ANALYSIS
5.4 PRICING ANALYSIS
Chapter 6. GLOBAL STEM CELL THERAPY MARKET, BY TYPE
6.1 INTRODUCTION
6.2 ALLOGENEIC
6.3 AUTOLOGOUS
Chapter 7. GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION
7.1 INTRODUCTION
7.2 MEDICINE
7.3 CARDIOVASCULAR DISEASES
7.4 BONE REGENERATION
7.5 NEURODEGENERATIVE DISORDERS
7.6 WOUND HEALING
7.7 TREATMENT OF EYES
7.8 HEMATOPOIETIC DISORDERS
7.9 METABOLIC DISORDERS
7.10 CANCER
7.11 IMMUNODEFICIENCY
7.12 DIABETES
Chapter 8. GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE
8.1 INTRODUCTION
8.2 ADIPOSE TISSUE
8.3 BONE MARROW
8.3 NEURAL
8.4 EMBRYO/CORD BLOOD-DERIVED
8.5 IPSCS
Chapter 9. GLOBAL STEM CELL THERAPY MARKET, BY END -USER
9.1 INTRODUCTION
9.2 BIOTECHNOLOGY COMPANIES
9.3 HOSPITALS & RESEARCH INSTITUTES
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.5 STEM CELL BANKS
Chapter 10. GLOBAL STEM CELL THERAPY MARKET, BY REGION
10.1 INTRODUCTION
10.2 AMERICA
10.2.1 NORTH AMERICA
10.2.1.1 US
10.2.1.2 CANADA
10.2.2 SOUTH AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 ITALY
10.3.1.4 SPAIN
10.3.1.5 UK
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 REPUBLIC OF KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 UNITED ARAB EMIRATES
10.5.2 SAUDI ARABIA
10.5.3 OMAN
10.5.4 KUWAIT
10.5.5 QATAR
10.5.6 REST OF THE MIDDLE EAST & AFRICA
Chapter 11. COMPANY LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS
11.3 KEY DEVELOPMENT & STRATEGIES
11.3.1 KEY DEVELOPMENTS
Chapter 12 COMPANY PROFILES
12.1 OSIRIS THERAPEUTICS, INC.
12.1.1 COMPANY OVERVIEW
12.1.2 PRODUCT TYPE OVERVIEW
12.1.3 FINANCIALS
12.2.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.2 MEDIPOST CO., LTD.
12.2.1 COMPANY OVERVIEW
12.2.2 PRODUCT TYPE OVERVIEW
12.2.3 FINANCIAL OVERVIEW
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.3 ANTEROGEN CO., LTD.
12.3.1 COMPANY OVERVIEW
12.3.2 PRODUCT TYPE OVERVIEW
12.3.3 FINANCIAL OVERVIEW
12.3.4 KEY DEVELOPMENT
12.3.5 SWOT ANALYSIS
12.4 PHARMICELL CO., LTD.
12.4.1 COMPANY OVERVIEW
12.4.2 PRODUCT TYPE/BUSINESS SEGMENT OVERVIEW
12.4.3 FINANCIAL OVERVIEW
12.4.4 KEY DEVELOPMENT
12.4.5 SWOT ANALYSIS
12.5 HOLOSTEM TERAPIE AVANZATE S.R.L.
12.5.1 COMPANY OVERVIEW
12.5.2 PRODUCT TYPE OVERVIEW
12.5.3 FINANCIAL OVERVIEW
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.6 JCR PHARMACEUTICALS CO., LTD.
12.6.1 COMPANY OVERVIEW
12.6.2 PRODUCT TYPE OVERVIEW
12.6.3 FINANCIAL OVERVIEW
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.7 NUVASIVE, INC
12.7.1 OVERVIEW
12.7.2 PRODUCT TYPE OVERVIEW
12.7.3 FINANCIALS
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.8 RTI SURGICAL, INC.
12.8.1 OVERVIEW
12.8.2 PRODUCT TYPE OVERVIEW
12.8.3 FINANCIALS
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.9 ALLOSOURCE
12.9.1 OVERVIEW
12.9.2 PRODUCT TYPE OVERVIEW
12.9.3 FINANCIALS
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.10 THERMO FISHER SCIENTIFIC
12.10.1 OVERVIEW
12.10.2 PRODUCT TYPE OVERVIEW
12.10.3 FINANCIALS
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.11 OTHERS
Chapter 14 APPENDIX
LIST OF TABLES
TABLE 1 STEM CELL THERAPY MARKET INDUSTRY SYNOPSIS, 2020-2027
TABLE 2 GLOBAL STEM CELL THERAPY MARKET ESTIMATES & FORECAST, 2020-2027, (USD MILLION)
TABLE 3 GLOBAL STEM CELL THERAPY MARKET, BY REGION, 2020-2027, (USD MILLION)
TABLE 4 GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 5 GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 7 GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 8 GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION
TABLE 9 NORTH AMERICA: GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 10 NORTH AMERICA: GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 12 NORTH AMERICA: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 13 NORTH AMERICA: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION)
TABLE 14 US: GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 15 US: GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 17 US: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 18 US: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION)
TABLE 19 CANADA: GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 20 CANADA: GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 22 CANADA: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 23 CANADA: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION)
TABLE 24 SOUTH AMERICA: GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 25 SOUTH AMERICA: GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 27 SOUTH AMERICA: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 28 SOUTH AMERICA: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION)
TABLE 29 EUROPE: GLOBAL STEM CELL THERAPY MARKET, TYPE, 2020-2027, (USD MILLION)
TABLE 30 EUROPE: GLOBAL STEM CELL THERAPY MARKET, THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 32 EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 33 EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION)
TABLE 34 WESTERN EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 35 WESTERN EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 37 WESTERN EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 38 WESTERN EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION
TABLE 39 EASTERN EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 40 EASTERN EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 42 EASTERN EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 43 EASTERN EUROPE: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION)
TABLE 44 ASIA-PACIFIC: GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 45 ASIA-PACIFIC: GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 47 ASIA-PACIFIC: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 48 ASIA-PACIFIC: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA: GLOBAL STEM CELL THERAPY MARKET, BY TYPE, 2020-2027, (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA: GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2020-2027, (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA: GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE, 2020-2027, (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA: GLOBAL STEM CELL THERAPY MARKET, BY END-USER, 2020-2027, (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 SEGMENTATION FOR THE GLOBAL STEM CELL THERAPY MARKET
FIGURE 3 MARKET DYNAMICS FOR GLOBAL STEM CELL THERAPY MARKET
FIGURE 4 GLOBAL STEM CELL THERAPY MARKET SHARE, BY TYPE 2020
FIGURE 4 GLOBAL STEM CELL THERAPY MARKET SHARE, BY PRODUCT TYPE 2020
FIGURE 5 GLOBAL STEM CELL THERAPY MARKET SHARE, BY CELL SOURCE 2020
FIGURE 6 GLOBAL STEM CELL THERAPY MARKET SHARE, BY END-USER, 2020
FIGURE 7 GLOBAL STEM CELL THERAPY MARKET SHARE, BY REGION, 2020
FIGURE 8 NORTH AMERICA STEM CELL THERAPY MARKET SHARE, BY COUNTRY, 2020
FIGURE 9 EUROPE STEM CELL THERAPY MARKET SHARE, BY COUNTRY, 2020
FIGURE 10 ASIA-PACIFIC STEM CELL THERAPY MARKET SHARE, BY COUNTRY, 2020
FIGURE 11 MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SHARE, BY COUNTRY, 2020
FIGURE 12 GLOBAL STEM CELL THERAPY MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 13 OSIRIS THERAPEUTICS, INC.: KEY FINANCIALS
FIGURE 14 OSIRIS THERAPEUTICS, INC.: SEGMENTAL REVENUE
FIGURE 15 OSIRIS THERAPEUTICS, INC.: GEOGRAPHICAL REVENUE
FIGURE 16 MEDIPOST CO., LTD.: KEY FINANCIALS
FIGURE 17 MEDIPOST CO., LTD.: SEGMENTAL REVENUE
FIGURE 18 MEDIPOST CO., LTD.: GEOGRAPHICAL REVENUE
FIGURE 19 ANTEROGEN CO., LTD.: KEY FINANCIALS
FIGURE 20 ANTEROGEN CO., LTD.: SEGMENTAL REVENUE
FIGURE 21 ANTEROGEN CO., LTD.: GEOGRAPHICAL REVENUE
FIGURE 22 PHARMICELL CO., LTD.: KEY FINANCIALS
FIGURE 23 PHARMICELL CO., LTD.: SEGMENTAL REVENUE
FIGURE 24 PHARMICELL CO., LTD.: GEOGRAPHICAL REVENUE
FIGURE 25 JCR PHARMACEUTICALS CO., LTD.: KEY FINANCIALS
FIGURE 26 JCR PHARMACEUTICALS CO., LTD.: SEGMENTAL REVENUE
FIGURE 27 JCR PHARMACEUTICALS CO., LTD.: GEOGRAPHICAL REVENUE
FIGURE 28 HOLOSTEM TERAPIE AVANZATE S.R.L.: KEY FINANCIALS
FIGURE 29 HOLOSTEM TERAPIE AVANZATE S.R.L. : SEGMENTAL REVENUE
FIGURE 30 HOLOSTEM TERAPIE AVANZATE S.R.L.: GEOGRAPHICAL REVENUE
FIGURE 31 NUVASIVE, INC: KEY FINANCIALS
FIGURE 32 NUVASIVE, INC: SEGMENTAL REVENUE
FIGURE 33 NUVASIVE, INC: GEOGRAPHICAL REVENUE
FIGURE 34 RTI SURGICAL, INC.: KEY FINANCIALS
FIGURE 35 RTI SURGICAL, INC.: SEGMENTAL REVENUE
FIGURE 36 RTI SURGICAL, INC.: GEOGRAPHICAL REVENUE
FIGURE 37 ALLOSOURCE: KEY FINANCIALS
FIGURE 38 ALLOSOURCE: SEGMENTAL REVENUE
FIGURE 39 ALLOSOURCE: GEOGRAPHICAL REVENUE
FIGURE 40 THERMO FISHER SCIENTIFIC: KEY FINANCIALS
FIGURE 41 THERMO FISHER SCIENTIFIC: SEGMENTAL REVENUE
FIGURE 42 THERMO FISHER SCIENTIFIC: GEOGRAPHICAL REVENUE
